Source: Cell Death & Disease. Unidades: ICB, FMRP, FCFRP, FM
Subjects: METFORMINA, PROLIFERAÇÃO CELULAR, APOPTOSE, MUTAÇÃO GENÉTICA, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO NETO, João Agostinho et al. Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms. Cell Death & Disease, v. 9, n. 3, p. 16 , 2018Tradução . . Disponível em: https://doi.org/10.1038/s41419-017-0256-4. Acesso em: 14 nov. 2024.APA
Machado Neto, J. A., Fenerich, B. A., Ribeiro, R. S., Eide, C. A., Silva, J. L. C. da, Dechandt, C. R. P., et al. (2018). Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms. Cell Death & Disease, 9( 3), 16 . doi:10.1038/s41419-017-0256-4NLM
Machado Neto JA, Fenerich BA, Ribeiro RS, Eide CA, Silva JLC da, Dechandt CRP, Fernandes JC, Alves APNR, Scheucher PS, Simões BP, Alberici LC, Pontes LL de F, Tognon CE, Druker BJ, Rego EM, Traina F. Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms [Internet]. Cell Death & Disease. 2018 ; 9( 3): 16 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1038/s41419-017-0256-4Vancouver
Machado Neto JA, Fenerich BA, Ribeiro RS, Eide CA, Silva JLC da, Dechandt CRP, Fernandes JC, Alves APNR, Scheucher PS, Simões BP, Alberici LC, Pontes LL de F, Tognon CE, Druker BJ, Rego EM, Traina F. Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms [Internet]. Cell Death & Disease. 2018 ; 9( 3): 16 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1038/s41419-017-0256-4